Overcoming Resistance to FLT3 Inhibitors in the Treatment of <i>FLT3</i>-Mutated AML

by Stephen S.Y. Lam, Anskar Y.H. Leung
Published 2020-02-01

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy

by Harinder Gill, Anskar Y. H. Leung, Yok-Lam Kwong
Published 2016-03-01

Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment

by Harry H. S. Gill, Anskar Y. H. Leung, N. J. Trendell-Smith, C. K. Yeung, Raymond Liang
Published 2010-01-01

Efficient RNA drug delivery using red blood cell extracellular vesicles

by Waqas Muhammad Usman, Tin Chanh Pham, Yuk Yan Kwok, Luyen Tien Vu, Victor Ma, Boya Peng, Yuen San Chan, Likun Wei, Siew Mei Chin, Ajijur Azad, Alex Bai-Liang He, Anskar Y. H. Leung, Mengsu Yang, Ng Shyh-Chang, William C. Cho, Jiahai Shi, Minh T. N. Le
Published 2018-06-01

Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies

by Gordon K. C. Leung, H. M. Luk, Vincent H. M. Tang, W. W. Gao, Christopher C. Y. Mak, Mullin H. C. Yu, W. L. Wong, Yoyo W. Y. Chu, W. L. Yang, Wilfred H. S. Wong, Alvin C. H. Ma, Anskar Y. H. Leung, D. Y. Jin, Kelvin Y. K. Chan, Judith Allanson, Ivan F. M. Lo, Brian H. Y. Chung
Published 2018-02-01